Vor Biopharma Inc. (VOR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 500.78M | 458.11M | 172.49M | 204.93M | 64.85M | 96.51M | 67.3M | 90.26M | 111.82M | 140.8M | 164.44M | 191.39M |
| Cash & Short-Term Investments | 491.52M | 455.21M | 170.46M | 202.98M | 60.03M | 91.93M | 62.81M | 85.94M | 107.48M | 137.18M | 160.1M | 186.9M |
| Cash Only | 169.87M | 396.49M | 160.46M | 192.99M | 50.05M | 81.95M | 52.8M | 76.08M | 44.96M | 31.36M | 45.03M | 32.21M |
| Short-Term Investments | 321.65M | 58.72M | 10M | 9.99M | 9.99M | 9.98M | 10.01M | 9.86M | 62.52M | 105.81M | 115.07M | 154.69M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 9.25M | 2.9M | 1.28M | 449K | 297K | 380K | 285K | 272K | 507K | 475K | 667K | 539K |
| Total Non-Current Assets | 5.97M | 6.02M | 3.75M | 444K | 44.47M | 56.51M | 48.7M | 51.33M | 55.21M | 69.03M | 58.59M | 59.59M |
| Property, Plant & Equipment | 3.39M | 3.47M | 3.31M | 24K | 39.68M | 41.59M | 43.77M | 45.86M | 47.98M | 50.1M | 52.09M | 53.91M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 168K | 0 | 0 | 0 | 2.41M | 2.41M | 0 | 2.41M | 2.41M | 0 |
| Other Non-Current Assets | 2.58M | 2.55M | 269K | 420K | 4.78M | 14.92M | 2.51M | 3.06M | 7.23M | 4.81M | 4.09M | 5.68M |
| Total Assets | 506.75M | 464.13M | 176.24M | 205.37M | 109.31M | 142.89M | 115.99M | 141.59M | 167.03M | 209.83M | 223.02M | 250.99M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 363.58% | 224.81% | 51.94% | 45.05% | -34.56% | -31.9% | -47.99% | -43.59% | -39.82% | -29.91% | 8.07% | 11.74% |
| Total Current Liabilities | 16.08M | 25.17M | 18.84M | 58.77M | 16.73M | 18.61M | 14.35M | 13.8M | 13.21M | 15.57M | 15.39M | 12.72M |
| Accounts Payable | 1.04M | 5.13M | 885K | 669K | 3.73M | 1.5M | 1.32M | 2.01M | 2.33M | 815K | 1.31M | 1.65M |
| Days Payables Outstanding | 9.92K | - | - | - | - | 150.02 | - | 219.01 | 151.51 | 109.53 | - | - |
| Short-Term Debt | 307K | 280K | 252K | 0 | 0 | 0 | 0 | 0 | 0 | 3.83M | 3.74M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 14.73M | 15.33M | 13.07M | 45.35M | 2.15M | 6.21M | 4.15M | 4.27M | 2.04M | 4.96M | 6.07M | 22K |
| Current Ratio | 31.15x | 18.20x | 9.16x | 3.49x | 3.88x | 5.19x | 4.69x | 6.54x | 8.46x | 9.04x | 10.69x | 15.05x |
| Quick Ratio | 31.15x | 18.20x | 9.16x | 3.49x | 3.88x | 5.19x | 4.69x | 6.54x | 8.46x | 9.04x | 10.69x | 15.05x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 641.09M | 603.27M | 2.38B | 1.65B | 26.52M | 27.61M | 28.69M | 29.71M | 30.78M | 43.53M | 32.85M | 33.82M |
| Long-Term Debt | 2.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 2.72M | 2.81M | 0 | 26.52M | 27.61M | 28.69M | 29.71M | 30.78M | 31.83M | 32.85M | 33.82M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.7M | 0 | 0 |
| Other Non-Current Liabilities | 638.46M | 600.55M | 2.38B | 1.65B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 657.17M | 628.44M | 2.4B | 1.71B | 43.24M | 46.23M | 43.04M | 43.51M | 43.99M | 59.1M | 48.24M | 46.54M |
| Total Debt | 2.94M | 3M | 3.06M | 0 | 30.78M | 31.83M | 32.85M | 33.82M | 34.74M | 35.66M | 36.6M | 37.51M |
| Net Debt | -166.93M | -393.49M | -157.4M | -192.99M | -19.27M | -50.12M | -19.94M | -42.26M | -10.22M | 4.3M | -8.43M | 5.3M |
| Debt / Equity | - | - | - | - | 0.47x | 0.33x | 0.45x | 0.34x | 0.28x | 0.24x | 0.21x | 0.18x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | -150.42M | -164.31M | -2.23B | -1.51B | 66.07M | 96.66M | 72.95M | 98.08M | 123.03M | 150.72M | 174.78M | 204.45M |
| Equity Growth % | -327.68% | -269.98% | -3150.49% | -1635.18% | -46.3% | -35.87% | -58.26% | -52.03% | -46.56% | -39.86% | 10.11% | 16.85% |
| Book Value per Share | -349.73 | -16.64 | -333.07 | -240.39 | 10.59 | 28.14 | 21.31 | 28.72 | 36.17 | 44.40 | 51.70 | 61.00 |
| Total Shareholders' Equity | -150.42M | -164.31M | -2.23B | -1.51B | 66.07M | 96.66M | 72.95M | 98.08M | 123.03M | 150.72M | 174.78M | 204.45M |
| Common Stock | 19K | 18K | 15K | 13K | 13K | 13K | 7K | 7K | 7K | 7K | 7K | 7K |
| Retained Earnings | -1.37B | -1.15B | -2.88B | -2.06B | -489.48M | -456.99M | -426.28M | -398.72M | -370.88M | -340.08M | -313.82M | -280.63M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -706K | 41K | 12K | 14K | 23K | 22K | 68K | -70K | -87K | -77K | -280K | -436K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |